Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases
US11730748B2 · kind B2 · utility
0Cited by
13References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2020 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Apr 30, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/213
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to Compounds of Formula (I) or Formula (II): or a pharmaceutically acceptable salt, solvate or enantiomer thereof, wherein A, B, R1, R2, R3, R4, Q and V are as defined herein. The present invention also relates to pharmaceutical compositions comprising a Compound of Formula (I) or Formula (II) and to their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.